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Abstract  
Annotation of the 330-kb Chlorella virus PBCV-1 ge-
nome identified a 237 nucleotide gene (a438l) that codes 
for a protein with ~35% amino acid identity to glu-
taredoxins (Grx) found in other organisms. The PBCV-
1 protein resembles classical Grxs in both size (9 kDa) 
and location of the active site (N-terminus). However, 
the PBCV-1 Grx is unusual because it contains a mono-
thiol active site (CPYS) rather than the typical dithiol ac-
tive site (CPYC). To examine this unique active site, four 
site-specific mutants (CPYC, CPYA, SPYC, and SPYS) 
were constructed to determine if the N-terminal cyste-
ine is necessary for enzyme activity. Wild type and both 
mutants containing N-terminal cysteines catalyzed the 
reduction of disulfides in a coupled system with GSH, 
NADPH, and glutathione reductase. However, both 
mutants with an altered N-terminal cysteine were inac-
tive. The grx gene is common in the Chlorella viruses. 
Molecular phylogenetic analyses of the PBCV-1 enzyme 
support its relatedness to those from other Chlorella vi-
ruses and yet demonstrate the divergence of the Grx 
molecule. 
Keywords:  Chlorella viruses, Phycodnaviridae, Virus 
PBCV-1, Monothiol glutaredoxin, Classical glutaredoxin 
Introduction
Glutaredoxins (Grxs) are a major source of reducing 
power in almost all living cells. They participate in a va-
riety of cellular functions, such as providing reducing 
equivalents for ribonucleotide reductase, antioxidant 
defense, control of cellular redox state, and the redox 
control of transcription and signal transduction (for re-
cent reviews on Grxs see Refs. [1–3]). To perform redox 
reactions, Grxs have evolved two catalytic mechanisms 
[3, 4]. The dithiol mechanism uses the two adjacent Cys 
residues in the active site (usually CPYC) to reduce pro-
tein–S–S or protein–S–S–glutathione substrates [5, 6]. 
The alternative monothiol mechanism (usually active 
site CGFS) can only reduce protein–S–S–glutathione 
substrates [1, 5]. 
There are four classes of Grxs based on their struc-
ture and catalytic mechanism [4, 7–11]. Members of the 
first class, commonly referred to as classical Grxs, are 9–
12 kDa in size. Members of the second class, e.g., present 
in Escherichia coli, are twice the size of the classical Grx 
(24.3 kDa) [12]. Both of these classes have a dithiol active 
site that is typically a CPYC sequence located near the 
N-terminus [13, 14]. Members in the third class contain 
a monothiol active CGFS site that is located in the cen-
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tral portion of a 9–12 kDa protein [13]. More recently, a 
fourth class of Grxs has been described in higher plants. 
This class is referred to as CC due to the active sites con-
sisting of either CCXC or CCXS [9–11]. 
Annotation of the 330-kb dsDNA genome of Chlo-
rella virus PBCV-1, the prototype virus of the genus 
Chlorovirus (family Phycodnaviridae), revealed an open 
reading frame (ORF) encoding a putative Grx [15]. This 
virus-encoded Grx is similar to classical Grxs with its 9-
kDa size and the location of its active site in the N-ter-
minus. However, the active site is unusual because it 
contains a monothiol (CPYS) rather than the typical di-
thiol. Herein, we demonstrate that the PBCV-1 encoded 
protein has Grx activity. We also determined that the ac-
tive site must have a CXXX motif in the active site to be 
functional. 
Materials and methods
Strains and culture conditions
Viral hosts Chlorella NC64A and Chlorella Pbi, were 
grown on MBBM and FES media, respectively. The 
growth of the host, production and purification of the 
viruses, and the isolation of virus DNAs have been de-
scribed [16, 17]. E. coli strains DH5αMCR (E. coli Genetic 
Stock Center, New Haven, CT) and BL21(DE3)pLysS 
(Novagen, Madison, WI) were grown in Luria-Bertani 
(LB) medium [18]. 
Cloning and expression of PBCV-1 Grx
PBCV-1 gene a438l was cloned from viral DNA ampli-
fied by PCR with the following oligonucleotide primers: 
5′ Primer: GGTGGTCATATGTCGTTTAAATTATTTGTG
3′ Primer: CCGCTCGAGTTTTCTTAAATGTTTCAC
The NdeI and XhoI endonuclease recognition sites 
used for cloning are underlined. The a438l gene was 
amplified with KOD hot start DNA Polymerase (No-
vagen) in 50 μl reactions containing 100 ng of virus 
DNA, 15 pM of each primer, 0.2 mM each of dATP, 
dGTP, dCTP, dTTP and 1 mM MgSO4 by 35 cycles of 
heating and cooling: 15 s at 94°C for denaturing, 30 s 
at 60°C for annealing, 1 min at 68°C for elongation. The 
PCR products were purified from 1.2% agarose gels 
using a QIAEX II Gel Extraction kit (QIAGEN, Valen-
cia, CA), digested with NdeI and XhoI, and inserted 
into the NdeI/XhoI sites of the pET23a+ expression vec-
tor (Novagen). This resulted in the addition of a 6-His 
residue tag at the C-terminus of the target protein. 
The construction of the recombinant expression plas-
mid, named pETA438L, was confirmed by DNA se-
quencing. Plasmid, pETA438L, was transformed into 
either E. coli strain DH5αMCR (for maintenance) or 
BL21(DE3)pLysS (for expression). 
The Grx protein was expressed in E. coli BL21(DE3)/
pLysS, which contains the T7 RNA polymerase gene 
under control of the isopropyl-β-D-thiogalactopyrano-
side (IPTG) inducible lacUV5 promoter, and a plasmid 
constitutively expressing T7 lysozyme, an inhibitor of 
T7 RNA polymerase. Transformed cells were grown 
overnight in LB medium at 37°C. Flasks containing 
400 ml LB medium, which contain 100 μg/ml ampi-
cillin and 37 μg/ml chloramphenicol, were inoculated 
with 1/40 volume of the overnight culture, and incu-
bated at 37°C until the absorbance at 595 nm reached 
0.6–0.8. IPTG (Sigma, St. Louis, MO) was added to 
a final concentration of 0.5 mM, and incubation was 
continued for 2 h at 30°C. One liter of cells was har-
vested by centrifugation at 5,000×g for 5 min and re-
suspended in 50 ml NPI-10 buffer (50 mM phosphate 
buffer, pH 8.0; 300 mM NaCl; 10 mM imidazole). The 
cells were disrupted on ice by sonication for 4 min us-
ing a Tekmar sonic disruptor at 100% amplitude, in 
5 s pulses. The sonicated samples were centrifuged at 
12,000×g for 10 min to separate soluble and insoluble 
fractions. Ni-NTA agarose beads (Qiagen, Hilden, Ger-
many) equilibrated with NPI-10 buffer were added to 
the soluble fraction. After mixing for 1 h at 4°C, the 
resin was loaded in a column and washed with 20 col-
umn volumes of NPI-20 buffer (50 mM phosphate 
buffer, pH 8.0, 300 mM NaCl, 20 mM imidazole). Re-
combinant Grx protein was eluted from the column 
by NPI-250 buffer (50 mM phosphate buffer, pH 8.0, 
300 mM NaCl, 250 mM imidazole). Fractions contain-
ing the recombinant proteins were pooled, and protein 
concentrations were determined using the Lowry et al. 
method [19]. Glycerol was added to the sample until 
the final concentration was 50%, and stored at −20°C. 
Cloning and expression of mutant PBCV-1 Grxs
Three Grx mutants were constructed using 5′ primers 
containing a single amino acid change within the ac-
tive site located 11–14 amino acids from the N-terminus. 
In addition to the three single point mutants, a mutant 
was created which contained two mutations in the ac-
tive site. The first mutant created a classical Grx by al-
tering the wild type active site (CPYS) to the typical di-
thiol active site (CPYC). This was achieved by using the 
following 5′ primer that incorporated both the NdeI site 
(for cloning) and the serine to cysteine mutation within 
the active site.
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The changed codon is underlined and italicized and 
the nucleotide change is in bold. Below the primer se-
quence is the corresponding amino acid sequence with 
the active site indicated in bold and the point mutation 
underlined. In the second mutant, the wild type active 
site (CPYS) was mutated to CPYA using the following 
5′ primer:
The third construction mutated the N-termini cyste-
ine to a serine by using the following 5′ primer:
The fourth construction switched the N-terminal cys-
teine with the C-terminal serine, resulting in a CPYS to 
SPYC change, using the following primer:
Expression and purification of the mutant Grxs were 
carried out as described for wild type Grx.
Enzyme assays
Grx activity was determined by the assay developed by 
Mieyal et al. [20, 21] as modified by Raghavachari and 
Lou [22]. Unless otherwise noted, the reaction mixtures 
contained 0.2 mM NADPH, 0.5 mM GSH, 0.1 M Tris (pH 
8.5), 0.4 units of GSSG reductase, and an aliquot of puri-
fied Grx in a total volume of 1 ml. The reaction was in-
cubated at 37°C after a 5 min pre-incubation with 2 mM 
synthetic substrate, hydroxyethyldisulfide (HEDS). The 
decrease in absorbance of NADPH at 340 nm was mon-
itored for 5 min using a Beckman DU 640 Spectropho-
tometer (Beckman, Fullerton, CA). To determine Grx ac-
tivity, the slope of the linear portion of the time course 
for 340-nm absorption loss in a control (Grx-free) sam-
ple was subtracted from the slope of the experimental 
(Grx-containing) samples. One unit of Grx activity was 
defined as the amount of enzyme required to oxidize 
1 μmol of NADPH per min under these standard assay 
conditions. 
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Determination of optimal pH and temperature
The optimal pH for Grx activity was determined by per-
forming the standard assays (described above) at 25°C 
with a 10 mM mixture in each of the following buf-
fers: (1) Pipes (pKa 6.8; range 6.1–7.5), (2) Hepes (pKa 
7.5; range 6.8–8.2), (3) Tris (pKa 8.1; range 7–9), and (4) 
Capso (pKa 9.6; range 8.9–10.3). The optimal tempera-
ture for Grx activity was determined in Tris buffer (pH 
8.5) in a Beckman DU 640 Spectrophotometer with a Pel-
tier temperature control module. 
Dot blot analyses
Viral DNA used for dot blots was denatured and trans-
ferred to nylon membranes (Micron Separations Inc., 
Westborough, MA) as previously described [23]. DNA 
was hybridized to an antisense 32P-single-stranded full 
length grx probe (the grx probe was made using Invitro-
gen Random Primers DNA Labeling System) at 65°C in 
50 mM NaPO4, 1% BSA, and 2% SDS. After hybridiza-
tion, radioactivity bound to the membrane was detected 
using a Storm 840 Phosphorimager and ImageQuant 
software (Molecular Dynamics, Inc., Sunnyvale, CA). 
Phylogenetic analyses
A BLASTP search with the amino acid sequence of 
PBCV-1 A438L (AAC96806) was conducted using the 
NCBI non-redundant protein sequences database with 
default settings. An unrooted Bayesian inference, Mar-
kov chain Monte Carlo (MCMC), posterior probability 
tree, of 40 Grx protein sequences was generated based 
on sequence alignment using ClustalX-2.0.10 and Mr. 
Bayes within the Geneious Pro 4.5.4 software program 
[24]. The Poisson (fixed) amino acid gamma rate vari-
ation of four categories was used. MCMC settings of 
1,100,000 chain length, four heated chains at a temper-
ature setting of 0.2 and a sub-sampling of 200 with the 
burn in length of 100,000 analyzed 4,951 samples and 
produced the illustrated tree and clade support (clade 
support values of less than 0.50 are not displayed). 
MUSCLE alignments, Neighbor-Joining (Geneious Tree 
Builder, Jukes-Cantor Model and Maximum Likelihood 
(PHYML, Jones-Taylor-Thornton Model) phylogenies 
were carried out as well (data not shown) [24]. 
Other procedures
DNA and protein sequences were analyzed using the 
Genetics Computer Group (GCG) Wisconsin Package, 
v. 10.3 [25]. Alignment and shading of conserved nucle-
otides were created using Boxshade. The GenBank Ac-
cession Number for the PBCV-1 genome is U42580. The 
PBCV-1 ORF A438L GeneID number is 918084 and the 
protein number is AAC96806. 
Results
PBCV-1 ORF A438L resembles a Grx
Database searches using the predicted 365 PBCV-1 pro-
tein-encoding genes identified an ORF (A438L) with 
~35% amino acid identity with Grxs from prokaryotic 
and eukaryotic organisms. Amino acid alignment of 
A438L with Grxs from three eukaryotic and three pro-
karyotic organisms reveals that PBCV-1 Grx is most 
similar to classical Grxs (Figure 1). This similarity is 
evident in its size, the PBCV-1 Grx is 9 kDa and classi-
cal Grxs are typically 9–12 kDa. The second similarity 
is in the location of the enzymes’ active site, which oc-
curs in the N-terminal portion of the protein. However, 
one major difference between PBCV-1 Grx and other 
classical Grxs is the presence of a monothiol (CPYS) ac-
tive site instead of the typical dithiol (CPYC) active site 
found in most classical Grx enzymes. The G+C con-
tent of the amino acid coding portion of the a438l gene 
is 40%, a value identical to the entire PBCV-1 genome 
[26]. The 50 nucleotides upstream of the A438L ATG 
start codon, which could serve as the a438l transcrip-
tional start site, is 88% A+T. 
Expression and purification of recombinant PBCV-1 Grx
To determine if a438l encodes a functional Grx, a plasmid, 
pETA438L, was constructed to express a His-tagged re-
combinant enzyme in E. coli. Cells containing pETA438L 
produced the expected 9-kDa recombinant fusion protein 
after induction with IPTG. About 70% of the His-A438L 
protein is in the soluble fraction of the bacterial extracts. 
The protein was purified to apparent homogeneity over 
a Ni-NTA column. Approximately 0.5 mg of recombinant 
protein was obtained per liter of E. coli cells. 
Characterization of wild type and mutant PBCV-1 re-
combinant Grxs
Characterization of the wild type and four mutant 
PBCV-1 Grx enzymes revealed that recombinant pro-
teins, which contained a cysteine in the N-terminal posi-
tion of the active site, were functionally active. The two 
mutants containing an N-terminal serine had no detect-
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able enzyme activity. The three active enzymes had tem-
perature optima of 37°C (Figure 2) and pH optima of 8.5 
(Figure 3). All three enzymes retained significant activ-
ity from 25 to 42°C and at pHs of 6.5–10.0. 
The Km for HEDS was 2.1, 3.9, and 1.4 mM for 
CPYS, CPYC, and CPYA active site-containing en-
zymes, respectively (Table 1). A minimal difference in 
specific activity, 3.1–4.2 U/mg occurred between the 
wild type Grx and the two active mutants. The larg-
est kinetic difference occurred in the V max in which 
the CPYA active site was 4.5, the wild type CPYS ac-
tive site was 5.9, and the CPYC active site was 10.9 
(Table 1). PBCV-1 Grx does not require any metals for 
activity.
Figure 1. Multiple amino acid sequence alignments to PBCV-1 Grx. Amino acid alignment of Grxs coded by PBCV-1, three pro-
karyotic organisms (Bartonella tribocorum CIP 105476 [YP_001609045.1], Brucella canis ATCC 23365 [YP_001593681.1] and Ochrobac-
trum anthropi ATCC 49188 [YP_001369579.1]) and three eukaryotic organisms (Xenopus laevis [NP_001083654.1], Homo sapiens [NP_
001116860.1] and Equus caballus [XP_001504659.1]). The gray box indicates the glutaredoxin active site. 
Figure 2. Effect of temperature on PBCV-1 GRX wild type and 
site-specific mutants. All assays were run in triplicate with the 
same preparation of enzyme. Shown are the averages with 5% 
error bars. 
Figure 3. Effect of pH on PBCV-1 GRX wild type and site-spe-
cific mutants. All assays were run in triplicate with the same 
preparation of enzyme. Shown are the averages with 5% er-
ror bars. 
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Presence of a438l genes in other Chlorella viruses 
To determine if the a438l gene is common among the 
Chlorella viruses, genomic DNA from 47 Chlorella vi-
ruses isolated from diverse geographical regions were 
hybridized to an antisense 32P-single-stranded grx 
probe. DNA from 32 of the viruses that infect Chlorella 
NC64A hybridized strongly with the probe; weak or no 
hybridization occurred with 10 viruses that infect the 
same host (NC64A viruses) (Figure 4). No hybridization 
was detected with DNA from the Chlorella NC64A host 
or with DNA from four of the five viruses which infect 
Chlorella Pbi (Pbi viruses). These results indicate that grx 
genes are common among the Chlorella viruses. How-
ever, the lack of hybridization to some of the viruses 
may reflect either an absence of the gene in some of the 
viruses or, more likely, a substantially diverged gene 
that does not hybridize to the probe. 
Annotation of five additional, recently sequenced, 
Chlorella virus genomes revealed eight putative Grx 
[27–29]. Two of these sequenced viruses, NY-2A and 
AR158, are NC64A viruses and did not hybridize with 
the PBCV-1 probe. All three NC64A viruses encode a 
single Grx with a monothiol active site. However, the 
active sites for NY-2A and AR158 (CSYS) differ from 
PBCV-1’s active site (CPYS). Viruses MT325 and FR483 
are Pbi viruses and both viruses encode two dithiol 
Grxs with two different active sites, CRYC and CPHC. 
Finally, virus ATCV-1, which infects Chlorella SAG 3.83, 
encodes two Grxs. One Grx has the same active site 
found in one of the Pbi virus Grxs (CPHC) and the other 
Grx has a CKYC active site (Figure 5). 
Phylogenetic analysis
BLASTP analysis using the non-redundant amino acid 
NCBI database indicated the PBCV-1 Grx had the great-
est degree of sequence similarity to Grx enzymes pres-
ent in cyanobacteria and pathogenic Gram nega-
tive bacteria (Figure 1). A Bayesian inference posterior 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
probability tree indicates that the Grx molecules of the 
Chlorella viruses are closely related, yet display diversity 
when compared to Chlorella NC64A (the host of PBCV-1, 
NY-2A and AR158) and other organisms (Figure 6). Se-
quence alignments conducted for phylogenetic analyses 
indicate that while the three NC64A Chlorella viruses 
share the monothiol characteristic as well as the approx-
imate location of the active site (similar to first and sec-
ond class Grxs), the sequence of the active site of PBCV-1 
differs from that of AR158 and NY2A. This is demon-
strated in the sharing of a more recent common ancestor 
between the latter two (Figure 6). FR483 and MT325, vi-
ruses that infect Chlorella Pbi, and ATCV-1, which infects 
Chlorella SAG 3.83, each encode two Grxs which have di-
thiol active sites and share the same sequence. Prochloro-
coccus and Synechococcus phage encode molecules that 
are consistent with the first class Grx. Members of the 
family Phycodnaviridae belong to the Nucleocytoplas-
mic Large DNA Viruses (NLDV) group. It is believed 
Figure 4. Occurrence of the PBCV-1 grx gene in other Chlo-
rella viruses. Hybridization of the PBCV-1 a438l gene to DNAs 
isolated from the host Chlorella NC64A and 42 viruses that in-
fect Chlorella NC64A and five viruses that infect Chlorella Pbi 
(CVA-1, CVB-1, CVG-1, CVM-1, and CVR-1). The DNAs were 
hybridized with entire grx gene (237 bp) probes. The blots con-
tain 1, 0.5, 0.25, and 0.12 μg of DNA, left to right, respectively. 
Table 1. Kinetics of PBCV-1 Grx and four mutants 
  km (mM) Vmax  Specific activity (U/mg)
WT (CPYS) 2.1 5.9 3.4
CPYC 3.9 10.9 4.2
CPYA 1.4 4.5 3.1
SPYC No activity
SPYS No activity
Data was obtained from Lineweaver-Burk plots using five 
different substrate concentrations (0.33, 0.67, 1.00, 1.33, and 
2.00 mM HEDS). The R2 values for the plots were 0.99 in each 
case. 
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that members of this group shared a common ancestor 
2–3 billion years ago [30–32]. NLDV includes the Pox vi-
ruses (i.e. Vaccinia and Variola viruses, shown), Iridovi-
ruses (i.e. Invertebrate iridescent virus 6, shown), African 
Fever Virus (shown) and Acanthamoeba polyphaga mim-
ivirus. This large DNA virus shares the frequently con-
served dithiol, CPYC of these classes, yet the site is more 
central in location. These variations demonstrate the di-
versity of the Grx molecule and are supported by the 
phylogenetic analyses (Figure 6). MUSCLE alignments, 
Neighbor-Joining (Geneious Tree Builder, Jukes-Cantor 
Model and Maximum Likelihood (PHYML, Jones-Tay-
lor-Thornton Model) phylogenies support these findings 
(data not shown) [24]. 
Discussion
This study establishes that Chlorella virus PBCV-1, like 
many large dsDNA viruses, encodes a functional Grx. 
Sequence analysis indicates that this enzyme is similar 
to both prokaryotic and eukaryotic Grxs. 
There are four classes of Grx [4, 7–11]. The class I, or 
the classical Grxs are 9–12 kDa in size and they have a 
dithiol active site located near the N-terminus of the en-
zyme. This active site typically consists of CPYC. The 
second class also contains the dithiol CPYC active site 
near the N-terminus, however, this enzyme is 24 kDa 
in size. The third class, which is present in yeast, is 9–
12 kDa in size, however, they contain a monothiol 
(CGFS) active site located in the middle of the protein. 
Finally, the fourth class has only been found in higher 
plants and typically has a CCXC or CCXS sequence. 
PBCV-1 Grx is unusual because it does not easily fit 
in any of the four classes of Grxs. The PBCV-1 Grx 9-
kDa size excludes it from the second class of Grxs. The 
CPYS active site near the N-terminus places PBCV-1 Grx 
in the classical Grxs with an atypical active site. The re-
cently sequenced genome of the host Chlorella NC64A 
indicates it has a standard class III Grx (Fitzgerald et al. 
unpublished results). 
Classical dithiol Grxs contain a CPYC active site mo-
tif, which use both cysteine residues for the reduction of 
protein disulfides. A previous study mutated the CPYC 
active site of an E. coli Grx to determine which amino ac-
ids were necessary for activity [5]. Mutation in the C-ter-
minus cysteine resulted in a 50% loss of activity. 
In the current study, experiments were performed to 
determine the effect that mutation of either the cysteine 
or the serine located in the active site had on its activity. 
When the enzyme was mutated to the dithiol (CPYC) 
the specific activity and the Km were essentially the 
same but the V max was 2-fold higher than that of wild 
type Grx. When the serine in the active site was mutated 
to an alanine (CPYA), there was no difference in the ki-
netics compared to the wild type enzyme. The enzyme 
was completely inactive when the cysteine and the ser-
ine were switched (SPYC) or when no cysteines were 
present in the active site (SPYS). 
These results indicate that PBCV-1 Grx requires a 
cysteine in the N-terminal position of the active site to 
be active. The amino acid located in the C-terminal posi-
tion of the active site has little effect on enzyme activity. 
Gene a438l orthologs are probably present in all of the 
chloroviruses even though some of the virus genomes 
do not hybridize with the a438l probe. This supposition 
is supported by the finding that one or two grx genes 
exist in all five newly sequenced Chlorella viruses [27–
29]. However, the lack of hybridization to some virus 
genomes probably reflects considerable gene divergence 
Figure 5. Multiple amino acid sequence alignment of Chlorella virus Grxs similar to PBCV-1 Grx. The gray box indicates the Grx 
active site. 
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among these viruses. The phylogenetic analyses support 
the presence of the Grx molecule as being conserved 
across all domains of life, sharing similar motifs in some 
cases, yet at the same time displaying a high degree of 
diversity. Divergence is evident within the Chlorella vi-
ruses and there is some indication that this may be in 
a host dependent manner. As previously presented, the 
type virus, PBCV-1, does not display the complete set 
of characteristics of any of the designated classes, yet its 
single cell eukaryotic host Chlorella NC64A has a stan-
dard class III Grx species. 
Grx provides the reducing power to ribonucleotide 
reductase, a key enzyme for deoxyribonucleotide bio-
synthesis. The fact that PBCV-1 encodes a functional 
Grx and its sister enzyme thioredoxin is not unexpected 
since deoxyribonucleotide biosynthesis occurs extremely 
fast during its life cycle [33]. In fact, microarray experi-
ments indicate that the PBCV-1 grx gene is expressed as 
both an early and late gene in the virus life cycle, sug-
gesting its importance to viral replication (Yanai-Balser 
et al. manuscript in preparation). 
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Figure 6. Bayesian inference posterior probability phylogenetic tree of 40 glutaredoxin protein sequences. The phylogenetic tree 
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son fixed) amino acid rate matrix with gamma rate variation and 4 categories. MCMC parameters were chain length, 1,100,000, 
4 heated chains, temperature set at 0.2. The frequency of subsampling was 200 with burn in length of 100,000). The tree is “un-
rooted,” clade support values of less than 0.50 are not shown. 4951 tree samples were analyzed. Viruses AR158, NY2A and PBCV-
1 infect Chlorella NC64A (viral Grx homologs and Chlorella NC64A are in bold). Viruses FR483 and MT325 infect Chlorella Pbi and 
virus ATCV-1 infects Chlorella SAG 3.83 (hosts not shown, viral Grx homologs italicized). The latter three viruses each encode a 
second Grx, which are also shown. 
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